A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

A Solon Springs musher is working with the University of Minnesota's Canine Genetics Lab to research a rare disease and its ...

A Jan. 28 report on Medicare spending on lab tests indicated that spending on many types of tests flattened between 2022 and 2024, but spending on genetic tests rose 20% between 2023 and 2024 to $3.6 ...

Researchers at the University of Tasmania's Menzies Institute for Medical Research have received a $2.7milion grant for a new ...

Florida lab owner pleads guilty to a $52M Medicare fraud for unnecessary genetic testing, involving bribes and deceptive telemarketing, facing forfeiture and potential prison time.

Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands their pathology capabilities.

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

The United States genetic testing market presents lucrative growth opportunities driven by increasing disease prevalence, technological advancements, and supportive regulatory frameworks.

El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of laboratory acquisitions for a combined total of nearly $56 million. Fulgent ...

Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...